Related Experiment Video
Updated: Jul 11, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Heart failure management guidelines: New recommendations and implementation
1Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA.
Heart failure is rising due to aging populations, but new therapies and guidelines improve patient outcomes. This review covers recent advances in heart failure diagnosis and treatment, including new recommendations.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Increasing prevalence of heart failure globally, particularly in aging populations.
- Significant advancements in heart failure therapy enhance quality and length of life.
Purpose of the Study:
- To review key advances in heart failure diagnosis and treatment.
- To discuss new recommendations from the 2022 ACC/AHA/HFSA Guideline.
- To incorporate recent studies published post-guideline release.
Main Methods:
- Literature review focusing on the 2022 ACC/AHA/HFSA Guideline.
- Inclusion of relevant studies published after the guideline.
- Focus on specific areas: definition, LVEF treatments, devices, amyloidosis, iron deficiency, screening, PROs, and implementation.
Main Results:
- The review highlights updated definitions and medical treatments tailored to left ventricular ejection fraction.
- It covers the role of devices in diagnosis and treatment, and specific conditions like amyloidosis and iron deficiency.
- Emphasis is placed on screening for asymptomatic dysfunction, patient-reported outcomes, and implementation strategies.
Conclusions:
- Recent guidelines and therapies offer improved management strategies for heart failure.
- A comprehensive approach including updated definitions, targeted treatments, and patient-centered outcomes is crucial.
- Continued research and implementation of evidence-based practices are vital for advancing heart failure care.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Mitral Regurgitation IV: Nursing Management
Heart Failure VII: Nursing Interventions
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiomyopathy V: Interprofessional Care

